Suppressor of Tumorigenicity 2 as a Biomarker in Pulmonary Arterial Hypertension and its Association with REVEAL Risk Score in Riociguat-Treated Patients in the RESPITE Study
- Resource Type
- Abstract
- Source
- In
Journal of Heart and Lung Transplantation April 2019 38(4) Supplement:S96-S96 - Subject
- Language
- ISSN
- 1053-2498